BMI1 and liver cancer: Subsequent studies reported that NP treatment disrupts the spherical formation of cancer stem cells, which are the cause of metastasis in liver cancer, and reduces stem cell markers such as SOX2, BMI-1, Nanog and c-Myc by inhibiting stem cell genes.